Amgen (AMGN) Talks Catalysts with Management, Oppenheimer Sees MSD CAGR
Tweet Send to a Friend
Oppenheimer analyst Jay Olson reiterated an Outperform rating and $290.00 price target on Amgen (NASDAQ: AMGN) after meeting with management ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
